# To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test

> **NCT03233009** · NA · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 43 (actual)

## Conditions studied

- Skin Care

## Interventions

- **OTHER:** Experimental Daily Defense Serum A
- **OTHER:** Experimental Daily Defense Serum C
- **OTHER:** Experimental Daily Defense Serum G
- **OTHER:** Experimental Daily Defense Serum N
- **OTHER:** Saline Solution Sodium Chloride

## Key facts

- **NCT ID:** NCT03233009
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-22
- **Primary completion:** 2017-05-26
- **Final completion:** 2017-05-26
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2019-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03233009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03233009, "To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03233009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*